Thomas Ochsenkühn

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

Gert Van Assche, Julián Panés, Laurent Beaugerie et al. · Journal of Crohn s and Colitis · 2010 · 1.5K citations · Full text

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D’Haens, Filip Baert, Gert Van Assche et al. · The Lancet · 2008 · 1.2K citations

Autoimmune Disease, Immunosuppressive Therapy, Immunology +5

IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration

Stephan Brand, Florian Beigel, Torsten Olszak et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2006 · 540 citations

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD

Julia Seiderer, Ira Elben, Julia Diegelmann et al. · Inflammatory Bowel Diseases · 2007 · 324 citations · Full text

Increased serum deoxycholic acid levels in men with colorectal adenomas

E. Bayerdörffer, G. A. Mannes, Werner Richter et al. · Gastroenterology · 1993 · 235 citations

Gastroenterology, Pathology, Colorectal Cancer +4